You searched for "andrology"
Action Bladder Cancer UK offers grants for bladder cancer research
Action Bladder Cancer UK (ABC UK) is inviting applications for grants to support research into bladder cancer, encouraging projects that aim to improve bladder cancer care, treatment, or diagnosis.Prostate Cancer UK Clinical Champions Programme
Prostate Cancer UK have opened applications for their award-winning Clinical Champions Programme.
Is antibiotic prophylaxis warranted in hypospadias repairs?
Hypospadias repair is a common paediatric urological procedure. Complication rates following hypospadias repair are variable (ranging from 5–10% for distal hypospadias repairs and as high as 32–70% for proximal repairs). Limiting surgical site infections by minimising infection through antibiotic prophylaxis...Join Prostate Cancer Research Free Webinar for Healthcare Professionals
Managing Sexual Side Effects After Prostate Cancer: A Patient & Therapist Perspective Date: 20 January 2026 — 6.00pm (London)Register: https://zoom.us/webinar/register/WN_CstOkvaUSNSg_xlFI1Z27w Why attend?Sexual side effects remain one of the most challenging and under-discussed consequences of prostate cancer treatment. This focused webinar...Action Bladder Cancer UK offers nursing grants for projects supporting bladder cancer
Action Bladder Cancer UK (ABC UK) is inviting specialist urology and cancer nurses to apply for funding to deliver nurse-led projects that improve bladder cancer care, patient experience and treatment pathways. The ABC UK Nursing Grants Programme offers grants of...Poster Presentations for the ERIC Conference 2026
ERIC, The Children’s Bowel & Bladder Charity, are pleased to be hosting this year’s ERIC Conference for healthcare professionals, at The Grand Hotel in Bristol on 12 October 2026. The theme: Together for 35 years: leading change in paediatric bowel...
PARP inhibitors and prostate cancer
The discovery that BRCA1/2-deficient tumour cells are highly sensitive to poly-ADP ribose polymerase (PARP) inhibitors (PARPi) established the foundation of synthetic lethality in metastatic castration-resistant prostate cancer (mCRPC). The TOPARP-A trial confirmed clinical benefit, with PARPi activity largely restricted to...
Comparison of CHOKAI, STONE and STONE PLUS scores
The prevalence of urinary stones is steadily increasing due to changing dietary habits and living conditions, leading to a significant number of emergency department (ED) visits, primarily for severe pain. While managing pain is crucial, accurate diagnosis remains essential. Non-enhanced...The Hamilton Irving box – A reprise
In this series of articles, I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the third of these articles, written, in the spring of 2012, I...Focal therapies in prostate cancer
The standard of care in the management of prostate cancer has, to date, always been to treat the whole gland. This has ranged from surveillance, surgical excision / prostatectomy or external beam radiotherapy / whole gland brachytherapy. With the evolution...The BSoT buddy scheme at BAUS 2023: a new initiative for fostering international relationships
The BSoT committee at BAUS, many of whom where involved with the inaugural buddy scheme. The buddy background By Nicholas Boxall, Specialty Registrar, Cambridge University Hospitals NHS Foundation Trust; Immediate Past Chair of BSoT. The BAUS Section of Trainees (BSoT)...
